{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:37:20Z","timestamp":1791434240637,"version":"4.3.3"},"reference-count":25,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Context:<\/jats:title><jats:p>There is no therapy for control of hypercalciuria in nonoperable patients with primary hyperparathyroidism (PHPT). Thiazides are used for idiopathic hypercalciuria but are avoided in PHPT to prevent exacerbating hypercalcemia. Nevertheless, several reports suggested that thiazides may be safe in patients with PHPT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>To test the safety and efficacy of thiazides in PHPT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design:<\/jats:title><jats:p>Retrospective analysis of medical records.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting:<\/jats:title><jats:p>Endocrine clinic at a tertiary hospital.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients:<\/jats:title><jats:p>Fourteen male and 58 female patients with PHPT treated with thiazides.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interventions:<\/jats:title><jats:p>Data were compared for each patient before and after thiazide administration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcome Measures:<\/jats:title><jats:p>Effect of thiazide on urine and serum calcium levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Data are given as mean \u00b1 standard deviation. Treatment with hydrochlorothiazide 12.5 to 50 mg\/d led to a decrease in mean levels of urine calcium (427 \u00b1 174 mg\/d to 251 \u00b1 114 mg\/d; P &amp;lt; 0.001) and parathyroid hormone (115 \u00b1 57 ng\/L to 74 \u00b1 36 ng\/L; P &amp;lt; 0.001), with no change in serum calcium level (10.7 \u00b1 0.4 mg\/dL off treatment, 10.5 \u00b1 1.2 mg\/dL on treatment, P = 0.4). Findings were consistent over all doses, with no difference in the extent of reduction in urine calcium level or change in serum calcium level by thiazide dose.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Thiazides may be effective even at a dose of 12.5 mg\/d and safe at doses of up to 50 mg\/d for controlling hypercalciuria in patients with PHPT and may have an advantage in decreasing serum parathyroid hormone level. However, careful monitoring for hypercalcemia is required.<\/jats:p><\/jats:sec>","DOI":"10.1210\/jc.2016-2481","type":"journal-article","created":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T19:04:03Z","timestamp":1481742243000},"page":"1270-1276","source":"Crossref","is-referenced-by-count":32,"title":["Thiazide Treatment in Primary Hyperparathyroidism\u2014A New Indication for an Old Medication?"],"prefix":"10.1210","volume":"102","author":[{"given":"Gloria","family":"Tsvetov","sequence":"first","affiliation":[{"name":"Institute of Endocrinology, Diabetes and Metabolism, and"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 69978 Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dania","family":"Hirsch","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Diabetes and Metabolism, and"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 69978 Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Shimon","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Diabetes and Metabolism, and"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 69978 Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Benbassat","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Diabetes and Metabolism, and"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 69978 Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Masri-Iraqi","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Diabetes and Metabolism, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Gorshtein","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Diabetes and Metabolism, and"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 69978 Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Herzberg","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Diabetes and Metabolism, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzippy","family":"Shochat","sequence":"additional","affiliation":[{"name":"Statistical Consulting Unit, Rabin Medical Center - Beilinson Hospital, Petach Tikva, 4941492 Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana","family":"Shraga-Slutzky","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Diabetes and Metabolism, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talia","family":"Diker-Cohen","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Diabetes and Metabolism, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2016,12,14]]},"reference":[{"issue":"10","key":"2020071620244625300_B1","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2020071620244625300_B2","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1210\/jc.2014-1417","article-title":"Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism","volume":"99","author":"Marcocci","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071620244625300_B3"},{"issue":"6","key":"2020071620244625300_B4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.semnephrol.2011.09.008","article-title":"Diuretics and disorders of calcium homeostasis","volume":"31","author":"Grieff","year":"2011","journal-title":"Semin Nephrol"},{"key":"2020071620244625300_B5","first-page":"571","article-title":"Thiazide diuretics in renal hypercalciuria","volume":"16","author":"Aroldi","year":"1979","journal-title":"Proc Eur Dial Transplant Assoc"},{"issue":"2","key":"2020071620244625300_B6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0026-0495(73)90264-3","article-title":"Thiazide diuretics and calcium metabolism","volume":"22","author":"Middler","year":"1973","journal-title":"Metabolism"},{"issue":"3","key":"2020071620244625300_B7","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1210\/jc.2015-3964","article-title":"Thiazide-associated hypercalcemia: incidence and association with primary hyperparathyroidism over two decades","volume":"101","author":"Griebeler","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2020071620244625300_B8","doi-asserted-by":"crossref","first-page":"911.e9","DOI":"10.1016\/j.amjmed.2006.07.044","article-title":"Incidence and clinical spectrum of thiazide-associated hypercalcemia","volume":"120","author":"Wermers","year":"2007","journal-title":"Am J Med"},{"issue":"6","key":"2020071620244625300_B9","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1097\/MJT.0b013e3181c6c21b","article-title":"Thiazide-induced severe hypercalcemia: a case report and review of literature","volume":"17","author":"Desai","year":"2010","journal-title":"Am J Ther"},{"issue":"3","key":"2020071620244625300_B10","first-page":"338","article-title":"Thiazide therapy and severe hypercalcemia in a patient with hyperparathyroidism","volume":"154","author":"Strong","year":"1991","journal-title":"West J Med"},{"key":"2020071620244625300_B11"},{"issue":"8","key":"2020071620244625300_B12","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.amjmed.2014.02.044","article-title":"Risk of hypercalcemia in blacks taking hydrochlorothiazide and vitamin D","volume":"127","author":"Chandler","year":"2014","journal-title":"Am J Med"},{"issue":"664","key":"2020071620244625300_B13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/pgmj.57.664.80","article-title":"Primary hyperparathyroidism and thiazide diuretics","volume":"57","author":"Klimiuk","year":"1981","journal-title":"Postgrad Med J"},{"issue":"779","key":"2020071620244625300_B14","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/pgmj.66.779.714","article-title":"Failure of thiazide diuretics to increase plasma calcium in mild primary hyperparathyroidism","volume":"66","author":"Farquhar","year":"1990","journal-title":"Postgrad Med J"},{"issue":"2","key":"2020071620244625300_B15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF01656139","article-title":"Hyperparathyroidism with hypercalciuria and urolithiasis: long-term effects of parathyroid surgery and postoperative thiazide therapy","volume":"7","author":"Elomaa","year":"1983","journal-title":"World J Surg"},{"issue":"2","key":"2020071620244625300_B16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/cen.13046","article-title":"The influence of thiazide intake on calcium and parathyroid hormone levels in patients with primary hyperparathyroidism","volume":"85","author":"Riss","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2020071620244625300_B17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1365-2265.2001.01182.x","article-title":"Relationships with serum parathyroid hormone in old institutionalized subjects","volume":"54","author":"Stein","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071620244625300_B18"},{"issue":"2","key":"2020071620244625300_B19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1365-2796.2001.00868.x","article-title":"Effects of thiazide- and loop-diuretics, alone or in combination, on calcitropic hormones and biochemical bone markers: a randomized controlled study","volume":"250","author":"Rejnmark","year":"2001","journal-title":"J Intern Med"},{"key":"2020071620244625300_B20"},{"issue":"20","key":"2020071620244625300_B21","doi-asserted-by":"crossref","first-page":"19902","DOI":"10.1074\/jbc.M411961200","article-title":"Thiazide-sensitive NaCl-cotransporter in the intestine: possible role of hydrochlorothiazide in the intestinal Ca2+ uptake","volume":"280","author":"Bazzini","year":"2005","journal-title":"J Biol Chem"},{"issue":"5","key":"2020071620244625300_B22","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1172\/JCI117890","article-title":"Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia","volume":"95","author":"Arnold","year":"1995","journal-title":"J Clin Invest"},{"issue":"12","key":"2020071620244625300_B23","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/ajh\/hpv050","article-title":"Cardioprotective effect of thiazide-like diuretics: a meta-analysis","volume":"28","author":"Chen","year":"2015","journal-title":"Am J Hypertens"},{"issue":"1","key":"2020071620244625300_B24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2265.2009.03766.x","article-title":"Increased mortality and morbidity in mild primary hyperparathyroid patients","volume":"73","author":"Yu","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"2020071620244625300_B25","first-page":"CD005185","article-title":"Thiazide diuretics and the risk of hip fracture","author":"Aung","year":"2011","journal-title":"Cochrane Database Syst Rev"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/102\/4\/1270\/11205617\/jc.2016-2481.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/102\/4\/1270\/11205617\/jc.2016-2481.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T05:55:05Z","timestamp":1718949305000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/102\/4\/1270\/3109058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,14]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2016-2481","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,4,1]]},"published":{"date-parts":[[2016,12,14]]}}}